Form 4 for AGL agilon health, inc.
Accepted 2023-04-18 00:00:00 ET · period of report 2023-04-14 · accession 0001209191-23-024678 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-18 | 2023-04-14 | AGL | Sell Steven | CEO, Pres, Dir | F - Tax | $28.46 | -4,216 | 79.7K | -5% | -$120.0K |
| D | 2023-04-18 | 2023-04-14 | AGL | Sell Steven | CEO, Pres, Dir | A - Grant | $0.00 | +35.1K | 83.9K | +72% | $0 |
| D | 2023-04-18 | 2023-04-14 | AGL | Sell Steven | CEO, Pres, Dir | A - Grant | $0.00 | +60.8K | 60.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-14 | F | D | 4,216 | $28.46 | 79,687 | D | — | — | (F3) Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. (F2) Includes restricted stock units. |
| 2 | Common | Common Stock | 2023-04-14 | A | A | 35,138 | $0.00 | 83,903 | D | — | — | (F1) Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. (F2) Includes restricted stock units. |
| 3 | Derivative | Options (Rights to Buy) | 2023-04-14 | A | A | 60,754 | $0.00 | 60,754 | D | $28.46 · — to 2033-04-14 | 60,754 Common Stock | (F5) Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. |